Hydrotropic composition comprising at least one surface active cationic component, which is selected from a group of cholinium, guadinium or tetramethylguadinium, preferably cholinium, and a straight or branched carboxylate anion having at least six carbon atoms; and its uses, for treating of oil sands or the like, for treating tailings from separation of bitumen, asphaltenes or the like.

A metal double salt dispersion liquid including an organic solvent and a metal double salt, wherein the metal double salt has a composition represented by M(R.sup.1COO).sub.m-x-y(OH).sub.xA.sub.y(H.sub.2O).sub.z, where M is a metal element, R.sup.1 is a hydrogen atom or an alkyl group, A is an anion, m is a valence of the metal element M, 0<x+y<m, x>0, y≥0, and z≥0, and when the metal double salt dispersion liquid is subjected to a centrifugal operation at a relative centrifugal force of 10,000 G for 5 minutes, a proportion of metal elements not forming a precipitate to all metal elements contained in a total of the metal double salt dispersion liquid is 10.0 mol % or more.

The present invention relates to systems, compositions, and methods for the synthesis and use of imaging agents, or precursors thereof. An imaging agent precursor may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in .sup.18F. In some cases, an imaging agent may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs. In some embodiments, methods and compositions for assessing perfusion and innervation mismatch in a portion of a subject are provided.

The present invention relates to systems, compositions, and methods for the synthesis and use of imaging agents, or precursors thereof. An imaging agent precursor may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in .sup.18F. In some cases, an imaging agent may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs. In some embodiments, methods and compositions for assessing perfusion and innervation mismatch in a portion of a subject are provided.

The present invention relates to guanidine compounds for inhibiting mitochondrial oxidative phosphorylation (OXPHOS) and use thereof. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating a OXPHOS-related disease, particularly cancer, by inhibiting mitochondrial oxidative phosphorylation and reprogramming cellular metabolism.

The present invention relates to guanidine compounds for inhibiting mitochondrial oxidative phosphorylation (OXPHOS) and use thereof. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating a OXPHOS-related disease, particularly cancer, by inhibiting mitochondrial oxidative phosphorylation and reprogramming cellular metabolism.

The invention discloses compounds of the formula wherein A, B, X, Y and Z are defined. The compounds of the invention show activity against a range of bacteria, and are useful in the treatment or prophylaxis of a bacterial infection in an animal.

This invention relates to using a guanidinium-based ionic liquid as an absorbent material in an absorption chiller. The invention provides an absorption chiller comprising a mixture of a refrigerant and an absorbent, and the absorbent is a guanidinium-based ionic liquid. A preferred refrigerant is water. This invention also provides a method for synthesizing N,N,N′,N′,N″,N″-hexamethylguanidinium acetate.

This invention relates to using a guanidinium-based ionic liquid as an absorbent material in an absorption chiller. The invention provides an absorption chiller comprising a mixture of a refrigerant and an absorbent, and the absorbent is a guanidinium-based ionic liquid. A preferred refrigerant is water. This invention also provides a method for synthesizing N,N,N′,N′,N″,N″-hexamethylguanidinium acetate.

The present invention relates to linear guanidine derivatives, methods of preparation, uses and pharmaceutical compositions thereof. The compounds of Formulas 1 or 2 exhibit high antimicrobial activity against Gram positive and Gram negative bacteria.